This activity is expired and is no longer available for CME credit.


Retinal Disease Management During a Pandemic: Is it Remotely Possible?

Author(s)/Faculty: Arshad M. Khanani, MD, MA; Rishi P. Singh, MD
Release Date: 3/1/2021Expiration Date: 3/1/2022
Credit Type: CME / CME with ABO Continuing Certification Number of Credits: 0
Content Type: MonographProvider:
The COVID-19 pandemic has created unprecedented challenges in many aspects of life, and medical practice is no exception. In ophthalmology, direct observation of the eye requires face-to-face proximity with the patient within a few centimeters, a situation that now calls for both precaution and protocols. With much still unknown about the risks and long-term sequelae of COVID-19, authoritative guidelines and protocols based on clinical evidence are evolving. Medical institutions and experts have provided guidance for clinicians on best practices for diagnostic and treatment procedures, along with guidance on navigating the financial aspects of practice under these difficult conditions. Pandemic-related recommendations will necessarily change to incorporate shifting government-mandated policies as well as new knowledge about the nature of the SARS-CoV-2 virus. It is essential for the well-being of retinal specialists and their patients that they constantly monitor this evolving guidance. Retinal ophthalmologists can also mitigate risk to their patients by employing strategies such as telehealth virtual visits and selecting treatment regimens that require less frequent dosing. In this CME activity, expert faculty will examine telehealth options that can reduce the risk of exposure to COVID-19, as well as review new documentation requirements, practice management provisions, and best practices that can improve the use of telemedicine in the retina practice. They will also evaluate current and emerging long-interval treatment options for managing retinal disease.